Spirometry Market Provides an In-Depth Insight of Growth Factors and Upcoming Trends, Opportunities by Types and Application to 2026
Overview:
The global spirometry market is expecting to touch a
valuation of USD 1,106.46 million by 2023, according to Market Research Future
(MRFR). The high prevalence of
respiratory disorders is the major factor driving the market growth from 2018
to 2023 (forecast period). Rising cases of chronic obstructive pulmonary
disorders (COPD), technological advances in respiratory care devices, and the
expanding geriatric population are factors expected to spur market demand till 2023.
As per a report by Asthma UK in 2016, nearly 1,410 people died from asthma.
Government initiatives to curtail smoking habits, focus on
breathing diseases, rising levels of air pollution, and adoption of spirometers
at homes are factors likely to augur market growth. Awareness of reimbursement
policies among the public and clinicians are projected to drive patients
towards taking these tests. But high costs of spirometers can act as a
deterrent against market growth.
Segmentation:
The Spirometry
Market can be segmented by product, technology, application, and
end-user.
By product, the market is segmented into table-top
spirometry, hand-held spirometry, and desktop (PC) spirometry. The table-top
spirometry segment accounted for 49.9% market share in 2017, followed by
hand-held (31%), and desktop (19.1%). This can be attributed to adoption of
spirometers in hospitals and clinics. But the desktop segment is touted to
register the highest CAGR of 10.58% during the forecast period owing to its
rapid diagnosis rate and increasing use of computer-based applications.
By technology, the market covers flow measurement
spirometry, volume spirometry, and peak flow meters (PFM). The flow measurement
spirometry segment accounted for 50.3% share in 2017. This can be attributed to
its lightweight nature and compact size. Its functionality based on the
familiar table-top spirometer technology and lack of frequent calibration make
it popular among clinicians. But the PFM technology can register 10.58% CAGR
over the forecast period to reach USD 149.76 million by 2023.
Major applications of the spirometry market include
diagnostic and treatment monitoring. The diagnostic segment is further sub-segmented
into asthma, interstitial pulmonary fibrosis, and COPD. The diagnostic segment
accounted for 68.93% share of the market in 2017, spurred by the prevalence of
breathing diseases such as asthma. But the treatment monitoring segment can
exhibit the highest CAGR during the review period to reach a valuation of USD
353 million by 2023. Its valuation in 2018 was suggested to be USD 214.12
million.
Key market end-users include hospitals & clinics,
research & academic institutes, diagnostic centers, and home care. The home
care segment is projected to enjoy a 9.90% CAGR to reach a valuation of USD
71.14 million by 2023 from USD 44.38 million in 2018.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/6539
Regional Analysis:
The spirometry market covers the latest trends and
opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East
& Africa (MEA).
The Americas accounted for 39.74% share in the global market
in 2017, followed by Europe and APAC. This can be attributed to economies such
as the U.S. which are the earliest adopters of latest technologies coupled with
the large patient pool suffering from respiratory disorders. The region is
likely to enjoy a 10.25% CAGR over the forecast period.
The Europe spirometry market is expected to enjoy a CAGR
similar to the Americas market over the forecast period to touch a valuation of
USD 322.33 million by 2023. This can be credited to rising number of asthma
cases and ballooned healthcare expenditure of nations such as Germany and
France.
The MEA region can experience a respectable CAGR during the
review period owing to improvements of healthcare infrastructure and enhanced
healthcare budgets of Kuwait, Qatar, and Dubai.
The APAC region is expected to exhibit a 10.94% CAGR over
the forecast period owing to high cases of chronic diseases, awareness of
respiratory devices, and increased healthcare budgets of developed nations in
the region. The growing geriatric populace in China and Japan can contribute to
regional market revenue till 2023.
Competitive Dashboard:
Key players in the spirometry market include Smiths Medical
Inc. (U.S.), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), Hill-Rom
Holdings, Inc. (U.S.), Schiller AG (Switzerland), COSMED srl (Italy), Midmark
Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Carefusion
Corporation (U.S.), Nihon Kohden Corporation (Germany), and Koninklijke Philips
N.V. (The Netherlands).
Access Report @ https://www.marketresearchfuture.com/reports/spirometry-market-6539
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Comments
Post a Comment